Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.03−0.38 (-4.52%)
Close on Nov 18, 2026Market cap $466.86MP/E –Yield –
Capricor Therapeutics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Capricor Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$135.16M. For fiscal 2025 it was -$108.14M. The highest annual figure on record is -$2.10M in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$108.14M | – |
| FY2024 | Dec 31, 2024 | -$42.56M | – |
| FY2023 | Dec 31, 2023 | -$24.08M | – |
| FY2022 | Dec 31, 2022 | -$29.70M | – |
| FY2021 | Dec 31, 2021 | -$20.94M | – |
| FY2020 | Dec 31, 2020 | -$13.69M | – |
| FY2019 | Dec 31, 2019 | -$7.73M | – |
| FY2018 | Dec 31, 2018 | -$15.33M | – |
| FY2017 | Dec 31, 2017 | -$12.86M | – |
| FY2016 | Dec 31, 2016 | -$16.98M | – |
| FY2015 | Dec 31, 2015 | -$12.61M | – |
| FY2014 | Dec 31, 2014 | -$6.02M | – |
| FY2013 | Dec 31, 2013 | -$6.90M | – |
| FY2012 | Dec 31, 2012 | -$2.10M | – |
| FY2011 | Dec 31, 2011 | -$4.90M | – |
| FY2010 | Dec 31, 2010 | -$6.29M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$42.95M | – |
| Q1 FY2026 | Mar 31, 2026 | -$36.77M | – |
| Q4 FY2025 | Dec 31, 2025 | -$29.16M | – |
| Q3 FY2025 | Sep 30, 2025 | -$26.28M | – |
| Q2 FY2025 | Jun 30, 2025 | -$27.72M | – |
| Q1 FY2025 | Mar 31, 2025 | -$24.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.01M | – |
| Q2 FY2024 | Jun 30, 2024 | -$11.59M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.27M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.86M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.75M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.18M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.07M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.48M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.32M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.83M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.38M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.31M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.08M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.49M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.48M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.63M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.07M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.56M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.31M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.17M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.16M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.69M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.64M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.38M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.57M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.91M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.24M | – |
See a number that looks wrong?